drugset / Trial / NCT00604318
Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer
Phase 4
Completed
56 enrolled
Copenhagen University Hospital at Herlev
Odense University Hospital · collab
RandomizedCrossoverDouble-blindTreatment
Summary
To evaluate quality of life in patients after 10 days pause of thyroid medication (Liothyronine) compared to treatment with recombinant TSH (Thyrogen) before radioiodine uptake and treatment in a double-blinded, randomised cross-over design.
Timeline
- Start
- 2008-02
- Primary completion
- 2012-02
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | rhTSH | Protein / enzyme biologic | 0.9 mg | Other |